Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Aug 10, 2026
XLK ETF: Tracking Tech Sector Shifts and AI-Driven Rotations

XLK ETF: Tracking Tech Sector Shifts and AI-Driven Rotations

Key Takeaways

  • XLK provides concentrated exposure to the S&P 500 technology sector through ~77 holdings, with NVDA, AAPL, and MSFT accounting for roughly one-third of the portfolio.
  • The ETF has been roughly flat over the past 30 days, but that headline masks a sharp mid-July correction of approximately 10% followed by an equally forceful rebound.
  • A pronounced rotation from AI hardware and semiconductor names toward cloud computing and software platforms has defined recent trading, driven by diverging earnings narratives.
  • The expense ratio of just 0.08% and approximately $115–124 billion in AUM (assets under management) make XLK one of the most cost-efficient and liquid vehicles for broad U.S. technology exposure.
  • Key risks include ongoing monetary policy uncertainty, elevated AI capital expenditure scrutiny, and memory chip supply constraints affecting consumer hardware margins.

XLK ETF Structure and Top Holdings

The Technology Select Sector SPDR Fund seeks to track, before fees and expenses, the performance of the Technology Select Sector Index. That index represents the technology companies within the S&P 500, spanning industries such as semiconductors, software, IT services, communications equipment, and technology hardware. Launched in 1998 and managed by State Street Global Advisors, XLK is a passively managed, market-cap-weighted ETF with an expense ratio of 0.08% and approximately $115–124 billion in AUM.

The portfolio is notably top-heavy. The three largest holdings — NVDA (approximately 13–14%), AAPL (approximately 12–14%), and MSFT (approximately 8–9%) — together represent more than one-third of fund assets. Semiconductor and semiconductor-equipment companies collectively account for well over half the portfolio, making XLK highly sensitive to developments across the AI hardware supply chain. Other significant positions include AVGO, AMD, MU, INTC, CSCO, AMAT, and LRCX. This concentrated structure means that relatively few names can drive a disproportionate share of XLK's performance in either direction. I also checked the sector weightings using Tickeron’s AI Screener to compare XLK against peers.

The Broader Tech Landscape in 2026

The technology sector is navigating a transitional phase in 2026. After two years of breakneck AI infrastructure spending, investors are increasingly differentiating between companies that supply AI hardware and those that demonstrate actual revenue generation from AI. Global hyperscaler capital expenditure remains enormous — the four largest cloud providers are projected to spend roughly $7,450 billion combined in 2026 — but market attention has shifted from the scale of spending toward its return profile.

Several forces are reshaping the landscape. The release of highly capable open-source AI models, including a 2.8-trillion-parameter system from China, has challenged the assumption that ever-larger proprietary models require proportionally more GPU (graphics processing unit) capacity. Meanwhile, memory chip prices have surged dramatically — Apple's CEO described the situation as a "once-in-a-century" supply shock — as AI data center demand for high-bandwidth memory (HBM) and advanced DRAM crowds out supply for consumer electronics. The Federal Reserve held its benchmark rate steady at 3.50%–3.75% in July, but three dissenting votes in favor of a hike underscored internal divisions and kept rate uncertainty elevated. Geopolitical tensions involving the Middle East have also added intermittent energy-cost risk premiums. These cross-currents have produced a markedly bifurcated market: cloud and software platforms reached new highs while semiconductor names corrected sharply, erasing roughly $2 trillion in global market value before staging a partial recovery.

Recent Performance and Market Moves

XLK's recent trading pattern illustrates this bifurcation clearly. The ETF entered July near $186, then sold off to an intra-month low around $167 — a decline of approximately 10% from peak to trough — before rebounding to approximately $187 by early August. The net 30-day change is modest, but the round trip reflects intense cross-currents beneath the surface.

The July selloff was driven primarily by semiconductor exposure. Leveraged positioning in Korean memory-chip names unwound violently, and concerns about data center overcapacity weighed on the entire hardware complex. The Philadelphia Semiconductor Index retreated more than 20% from its late-June all-time high. MU and other memory-focused names bore the brunt of the decline, while NVDA held up comparatively well. The subsequent rebound was powered by cloud-platform earnings. MSFT reported 18% revenue growth with cloud services exceeding expectations, while AMZN and GOOGL posted similar cloud-driven beats. By contrast, AAPL declined sharply after warning that memory-chip shortages would compress margins, demonstrating how the same supply dynamic that benefits semiconductor suppliers can simultaneously hurt hardware customers.

Over the broader quarter, XLK's trajectory has been shaped by a rotation from pure-play AI hardware toward companies with visible AI monetization. The ETF's heavy semiconductor weighting meant it absorbed the full force of the July correction, but its diversified exposure to software and IT services provided ballast during the recovery. From what I see, this rotation highlights the need to monitor earnings differentiation closely.

Looking Ahead: Factors Shaping XLK in 2026

Several structural factors are likely to shape XLK's trajectory through the remainder of 2026. First, the AI capital-expenditure cycle is entering a more scrutinized phase. While aggregate spending remains enormous, consensus estimates point to a deceleration in year-over-year growth rates from roughly 78% in 2026 toward 41% in 2027. How markets price this deceleration — and whether it is interpreted as normalization or a warning sign — will heavily influence semiconductor-heavy portfolios like XLK.

Second, the memory-chip supply-demand imbalance is unlikely to resolve quickly. With only three major global DRAM suppliers and AI data centers absorbing an increasing share of advanced-node capacity, consumer hardware margins may remain under pressure. This dynamic creates a tension within XLK between semiconductor holdings that benefit from elevated pricing and hardware holdings such as AAPL that face input-cost headwinds.

Third, Federal Reserve policy remains a pivotal variable. The central bank's internal division over rate hikes introduces uncertainty around the discount rate applied to long-duration growth equities. Any shift toward tightening would disproportionately affect high-multiple technology names. Finally, the transition from AI infrastructure buildout to AI application adoption represents both an opportunity and a risk. If enterprise AI adoption accelerates faster than expected, software and cloud holdings within XLK could broaden the performance base beyond semiconductors. If adoption disappoints, the entire AI investment thesis may face a more fundamental reassessment. Monitoring earnings execution, capital allocation discipline, and the pace of enterprise AI deployment will be essential for understanding XLK's path forward.

AI Tools in My Research Process

When evaluating sector rotations like the one unfolding in technology, I often turn to Tickeron’s AI Screener to scan for patterns across holdings and compare momentum signals within the same industry group. It helps surface ideas that align with shifting leadership without manually reviewing every chart.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: XLK

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


XLK's RSI Oscillator climbs out of oversold territory

The RSI Indicator for XLK moved out of oversold territory on July 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 25 similar instances when the indicator left oversold territory. In of the 25 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 03, 2026. You may want to consider a long position or call options on XLK as a result. In of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for XLK just turned positive on August 04, 2026. Looking at past instances where XLK's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

XLK moved above its 50-day moving average on August 04, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XLK advanced for three days, in of 383 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for XLK crossed bearishly below the 50-day moving average on July 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

XLK broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for XLK entered a downward trend on August 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Apple (NASDAQ:AAPL), Microsoft Corp (NASDAQ:MSFT), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Cisco Systems (NASDAQ:CSCO), Applied Materials (NASDAQ:AMAT), Oracle Corp (NYSE:ORCL).

Industry description

The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Technology Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy, which means that the fund typically invests in substantially all of the securities represented in the index in approximately the same proportions as the index. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The fund is non-diversified.

Market Cap

The average market capitalization across the State Street®TechSelSectSPDR®ETF ETF is 372.29B. The market cap for tickers in the group ranges from 5.03B to 5.42T. NVDA holds the highest valuation in this group at 5.42T. The lowest valued company is EPAM at 5.03B.

High and low price notable news

The average weekly price growth across all stocks in the State Street®TechSelSectSPDR®ETF ETF was 39%. For the same ETF, the average monthly price growth was 45%, and the average quarterly price growth was 271%. PLTR experienced the highest price growth at 40%, while WDC experienced the biggest fall at -20%.

Volume

The average weekly volume growth across all stocks in the State Street®TechSelSectSPDR®ETF ETF was -24%. For the same stocks of the ETF, the average monthly volume growth was -10% and the average quarterly volume growth was -58%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 63
P/E Growth Rating: 52
Price Growth Rating: 38
SMR Rating: 42
Profit Risk Rating: 55
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
XLK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category Technology

Profile
Details
Category
Technology
Address
One Lincoln Street Cph0326Boston
Phone
N/A
Web
www.spdrs.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.